Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Dexamethasone for Mild Acute Pancreatitis
NCT01247961Phase 2Withdrawn
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2010
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone in acute pancreatitis (AP), sponsored by Brigham and Women's Hospital. Primary endpoint: Systemic Inflammation (measured by c-reactive protein level) at 48 hours. Planned start Nov 2010; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT01247961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01247961.